153 related articles for article (PubMed ID: 28128877)
1. Endoscopic findings of ipilimumab-induced colitis.
Satoh T; Ohno K; Kurokami T
Dig Endosc; 2017 May; 29(3):388-389. PubMed ID: 28128877
[No Abstract] [Full Text] [Related]
2. Flexible Sigmoidoscopy Rather than Colonoscopy Is Adequate for the Diagnosis of Ipilimumab-Associated Colitis.
Herlihy JD; Beasley S; Simmelink A; Maddukuri V; Amin A; Kamionek M; Jacobs C; Bossi K; Scobey M
South Med J; 2019 Mar; 112(3):154-158. PubMed ID: 30830228
[TBL] [Abstract][Full Text] [Related]
3. Infliximab for severe colitis associated with nivolumab followed by ipilimumab.
Fukumoto T; Fujiwara S; Tajima S; Tamesada Y; Sakaguchi M; Oka M; Nishigori C
J Dermatol; 2018 Jan; 45(1):e1-e2. PubMed ID: 28891241
[No Abstract] [Full Text] [Related]
4. Nivolumab-induced colitis in a patient with malignant melanoma: A case report and immunological analysis.
Miyashita A; Fukushima S; Tsukamoto H; Itai H; Miyamoto H; Nakahara S; Kubo Y; Kimura T; Kuriyama H; Ihn H
J Dermatol; 2019 Sep; 46(9):e339-e341. PubMed ID: 30908699
[No Abstract] [Full Text] [Related]
5. A Life-Threatening Cause of Colitis.
Jaswani TS; Grider DJ; Bern MJ
Gastroenterology; 2018 Jan; 154(1):35-36. PubMed ID: 28918915
[No Abstract] [Full Text] [Related]
6. Extracorporeal Photopheresis for Colitis Induced by Checkpoint-Inhibitor Therapy.
Apostolova P; Unger S; von Bubnoff D; Meiss F; Becher B; Zeiser R
N Engl J Med; 2020 Jan; 382(3):294-296. PubMed ID: 31940706
[No Abstract] [Full Text] [Related]
7. Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients.
Garcia-Neuer M; Marmarelis ME; Jangi SR; Luke JJ; Ibrahim N; Davis M; Weinberg J; Donahue H; Bailey N; Hodi FS; Buchbinder EL; Ott PA
Cancer Immunol Res; 2017 Apr; 5(4):286-291. PubMed ID: 28373217
[TBL] [Abstract][Full Text] [Related]
8. Diet-dependent toxicity of ipilimumab in metastatic melanoma.
Majenka P; Hoffmann M; Rötzer I; Dimitrakopoulou-Strauss A; Koschny R; Longerich T; Enk A; Hassel JC
Eur J Cancer; 2019 Jan; 106():220-224. PubMed ID: 30528806
[No Abstract] [Full Text] [Related]
9. Balancing the Checkpoint: Managing Colitis Associated with Dual Checkpoint Inhibitors and High-Dose Aspirin.
Hammami MB; Gill R; Thiruvengadam N; Oh DY; Beck K; Mahadevan U; Kattah MG
Dig Dis Sci; 2019 Mar; 64(3):685-688. PubMed ID: 30778872
[No Abstract] [Full Text] [Related]
10. Immunological Characteristics of Colitis Associated with Anti-CTLA-4 Antibody Therapy.
Bamias G; Delladetsima I; Perdiki M; Siakavellas SI; Goukos D; Papatheodoridis GV; Daikos GL; Gogas H
Cancer Invest; 2017 Aug; 35(7):443-455. PubMed ID: 28548891
[TBL] [Abstract][Full Text] [Related]
11. Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis.
Adler BL; Pezhouh MK; Kim A; Luan L; Zhu Q; Gani F; Yarchoan M; Chen J; Voltaggio L; Parian A; Lazarev M; Lauwers GY; Pawlik TM; Montgomery EA; Jaffee E; Le DT; Taube JM; Anders RA
J Intern Med; 2018 Jun; 283(6):568-577. PubMed ID: 29464806
[TBL] [Abstract][Full Text] [Related]
12. [Ipilimumab induced colitis].
Thielsen P; Svane IM
Ugeskr Laeger; 2015 Nov; 177(46):V66773. PubMed ID: 26573945
[No Abstract] [Full Text] [Related]
13. [Severe ipilimumab-induced ulcerative colitis remitting after infliximab therapy and secondary switching with pembrolizumab].
Yelehe-Okouma M; Granel-Brocard F; Hudziak H; Schmutz JL; Gillet P
Therapie; 2018; 73(3):291-293. PubMed ID: 29203065
[No Abstract] [Full Text] [Related]
14. Autoimmune meningoencephalitis in a melanoma patient treated with ipilimumab.
Choe JH; Andonian BJ; Kim GJ; Salama AK
Immunotherapy; 2016 Oct; 8(10):1163-7. PubMed ID: 27605066
[No Abstract] [Full Text] [Related]
15. Colitis in a Rheumatologic Patient.
Lui J; de la Fuente J; Halland M
Gastroenterology; 2020 Dec; 159(6):2034-2035. PubMed ID: 32371112
[No Abstract] [Full Text] [Related]
16. Ipilimumab-induced hypophysitis and ileocolitis: Serial pituitary MRI findings.
Singh D; Hsu CC; Kwan GN; Bhuta S
Neurol India; 2017; 65(1):165-166. PubMed ID: 28084260
[No Abstract] [Full Text] [Related]
17. Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitis.
Wright AP; Piper MS; Bishu S; Stidham RW
Aliment Pharmacol Ther; 2019 Jun; 49(12):1474-1483. PubMed ID: 31035308
[TBL] [Abstract][Full Text] [Related]
18. Ipilimumab-induced acute generalized exanthematous pustulosis in a patient with metastatic melanoma.
Hwang SJ; Carlos G; Wakade D; Sharma R; Fernandez-Penas P
Melanoma Res; 2016 Aug; 26(4):417-20. PubMed ID: 27031538
[TBL] [Abstract][Full Text] [Related]
19. Clinical, Endoscopic, and Histologic Characteristics of Ipilimumab-Associated Colitis.
Verschuren EC; van den Eertwegh AJ; Wonders J; Slangen RM; van Delft F; van Bodegraven A; Neefjes-Borst A; de Boer NK
Clin Gastroenterol Hepatol; 2016 Jun; 14(6):836-842. PubMed ID: 26748223
[TBL] [Abstract][Full Text] [Related]
20. [Histoseminar on inflammatory bowel diseases (IBD): Case n
Fléjou JF
Ann Pathol; 2017 Aug; 37(4):298-301. PubMed ID: 28734677
[No Abstract] [Full Text] [Related]
[Next] [New Search]